1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Huntington’s disease treatment market is undergoing rapid transformation, driven by advancing genetic understanding, emerging therapies, and patient-centered care approaches. Senior stakeholders are seeking clear strategy amid evolving clinical, regulatory, and geopolitical complexities.
Market Snapshot: Huntington’s Disease Treatment
This market is marked by a robust trajectory, shaped by heightened investment in gene-targeted and cell-based treatments alongside steady demand for symptomatic therapies. Over the past few years, growing clinical development, expedited regulatory pathways, and strategic collaborations have propelled new modalities forward at a sustained growth rate. The integration of advanced biomarkers and real-world evidence continues to influence market adoption, while regulatory agencies are facilitating earlier patient access through tailored review pathways.
Scope & Segmentation
The report offers targeted intelligence for strategy and investment, detailing segmentation and regional activity across the full therapeutic continuum.
- Treatment Type: Disease Modifying Therapies, Emerging Therapies, Symptomatic Therapies
- Therapeutic Class: Cell Based Agents, Gene Silencing Agents, Neuroprotective Agents, Neurotransmitter Modulators
- Delivery Mode: Intrathecal, Intravenous, Oral
- End User: Home Care Settings, Hospitals, Specialty Clinics
- Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Key Companies Profiled: Teva Pharmaceutical Industries Ltd, H. Lundbeck A/S, Roche Holding AG, Ionis Pharmaceuticals, Inc., Wave Life Sciences Ltd, uniQure N.V.
Key Takeaways for Senior Decision-Makers
- Gene silencing and stem cell therapies are shifting industry focus toward disease modification, with clinical validation supporting their progression into advanced trials.
- Precision medicine, leveraging molecular biomarkers and patient-reported outcomes, is actively influencing regulatory approvals and payer assessments in high-value markets.
- Adaptive clinical trial designs and dynamic regulatory approaches are shortening development timelines for novel therapeutics.
- Patient-centric delivery modes, including oral and home-based options, are set to increase adherence and broaden access.
- Public-private partnerships continue to catalyze knowledge sharing, derisk development, and expedite time-to-market for breakthrough therapeutics.
- Integrated manufacturing models and supply chain diversification are emerging as best practices to address operational risks, particularly as product complexity grows.
Tariff Impact: United States 2025 Trade Policy
New tariff measures enacted in the United States in 2025 have directly influenced Huntington’s disease therapy R&D operations. Manufacturers have increased focus on domestic sourcing and alternative supplier qualification, leading to some extended development timelines. Elevated costs are prompting innovative pricing strategies, particularly for gene and cell-based products, and fostering a shift toward integrated production hubs to mitigate future supply chain disruptions. Continuing collaboration with contract manufacturing partners and regional diversification have helped maintain clinical program momentum and patient access.
Methodology & Data Sources
The analysis relies on a multi-stage research process including systematic secondary reviews of literature, regulatory filings, and clinical data sources. Primary insights were gained through interviews with neurologists, regulatory experts, and industry stakeholders. Cross-referencing stakeholder input with trial results and policy shifts underpins data validation and trend accuracy.
Why This Report Matters
- Enables informed investment and partnership decisions across diverse therapeutic classes, delivery modes, and regional markets.
- Provides evidence-based analysis of emerging opportunities amid regulatory, clinical, and economic complexity.
- Equips leadership with actionable strategies to balance risk, accelerate commercialization, and sustain innovation.
Conclusion
Stakeholders navigating the Huntington’s disease treatment market must align innovation with operational resilience and regulatory readiness. This report provides a comprehensive perspective to enable agile strategic planning in a rapidly evolving therapeutic landscape.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid advances in gene-silencing therapies targeting mutant huntingtin messenger RNA sequences with improved delivery mechanisms
5.2. Growing momentum behind CRISPR-based genome editing approaches for precise correction of pathogenic HTT alleles in preclinical models
5.3. Expansion of antisense oligonucleotide development pipelines demonstrating enhanced central nervous system penetration and safety profiles in early trials
5.4. Increased investment and strategic partnerships focusing on biomarker discovery to enable early diagnosis and disease progression monitoring
5.5. Emergence of novel small molecule neuroprotective agents with multi-modal mechanisms targeting synaptic dysfunction in Huntington’s disease
5.6. Regulatory agencies updating guidelines to facilitate accelerated approval pathways and conditional authorizations for rare neurological disorders
5.7. Implementation of wearable digital health platforms for real-time patient monitoring and outcome measures in Huntington’s disease clinical studies
5.8. Rising emphasis on patient-centric trial designs incorporating quality-of-life endpoints and stakeholder engagement across drug development pipelines
5.2. Growing momentum behind CRISPR-based genome editing approaches for precise correction of pathogenic HTT alleles in preclinical models
5.3. Expansion of antisense oligonucleotide development pipelines demonstrating enhanced central nervous system penetration and safety profiles in early trials
5.4. Increased investment and strategic partnerships focusing on biomarker discovery to enable early diagnosis and disease progression monitoring
5.5. Emergence of novel small molecule neuroprotective agents with multi-modal mechanisms targeting synaptic dysfunction in Huntington’s disease
5.6. Regulatory agencies updating guidelines to facilitate accelerated approval pathways and conditional authorizations for rare neurological disorders
5.7. Implementation of wearable digital health platforms for real-time patient monitoring and outcome measures in Huntington’s disease clinical studies
5.8. Rising emphasis on patient-centric trial designs incorporating quality-of-life endpoints and stakeholder engagement across drug development pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Huntington’s Disease Treatment Market, by Treatment Type
8.1. Introduction
8.2. Disease Modifying Therapies
8.2.1. Gene Silencing Therapies
8.2.2. Neuroprotective Therapies
8.3. Emerging Therapies
8.3.1. RNA Interference Therapies
8.3.2. Stem Cell Therapies
8.4. Symptomatic Therapies
8.4.1. Movement Disorder Treatments
8.4.2. Psychiatric Symptom Treatments
8.4.2.1. Depression Treatments
8.4.2.2. Psychosis Treatments
8.2. Disease Modifying Therapies
8.2.1. Gene Silencing Therapies
8.2.2. Neuroprotective Therapies
8.3. Emerging Therapies
8.3.1. RNA Interference Therapies
8.3.2. Stem Cell Therapies
8.4. Symptomatic Therapies
8.4.1. Movement Disorder Treatments
8.4.2. Psychiatric Symptom Treatments
8.4.2.1. Depression Treatments
8.4.2.2. Psychosis Treatments
9. Huntington’s Disease Treatment Market, by Therapeutic Class
9.1. Introduction
9.2. Cell Based Agents
9.3. Gene Silencing Agents
9.4. Neuroprotective Agents
9.5. Neurotransmitter Modulators
9.2. Cell Based Agents
9.3. Gene Silencing Agents
9.4. Neuroprotective Agents
9.5. Neurotransmitter Modulators
10. Huntington’s Disease Treatment Market, by Delivery Mode
10.1. Introduction
10.2. Intrathecal
10.3. Intravenous
10.4. Oral
10.2. Intrathecal
10.3. Intravenous
10.4. Oral
11. Huntington’s Disease Treatment Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Huntington’s Disease Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Huntington’s Disease Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Huntington’s Disease Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd
15.3.2. H. Lundbeck A/S
15.3.3. Roche Holding AG
15.3.4. Ionis Pharmaceuticals, Inc.
15.3.5. Wave Life Sciences Ltd
15.3.6. uniQure N.V.
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd
15.3.2. H. Lundbeck A/S
15.3.3. Roche Holding AG
15.3.4. Ionis Pharmaceuticals, Inc.
15.3.5. Wave Life Sciences Ltd
15.3.6. uniQure N.V.
List of Figures
FIGURE 1. HUNTINGTON’S DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUNTINGTON’S DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUNTINGTON’S DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUNTINGTON’S DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUNTINGTON’S DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. HUNTINGTON’S DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUNTINGTON’S DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY RNA INTERFERENCE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY RNA INTERFERENCE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY MOVEMENT DISORDER TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY MOVEMENT DISORDER TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DEPRESSION TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DEPRESSION TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHOSIS TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHOSIS TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY CELL BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY CELL BASED AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROTRANSMITTER MODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROTRANSMITTER MODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 204. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 205. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 206. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 207. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 220. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 221. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 222. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 223. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 252. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 253. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 254. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 255. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 258. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 259. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 260. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 261. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 262. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 263. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 268. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 269. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 270. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 271. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM T
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY RNA INTERFERENCE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY RNA INTERFERENCE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY MOVEMENT DISORDER TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY MOVEMENT DISORDER TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DEPRESSION TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DEPRESSION TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHOSIS TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHOSIS TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY CELL BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY CELL BASED AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY GENE SILENCING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROTRANSMITTER MODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY NEUROTRANSMITTER MODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 204. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 205. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 206. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 207. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 220. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 221. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 222. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 223. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 252. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 253. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 254. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 255. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 258. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 259. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 260. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 261. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 262. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 263. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 268. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 269. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 270. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 271. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY DISEASE MODIFYING THERAPIES, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY EMERGING THERAPIES, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC THERAPIES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM TREATMENTS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES HUNTINGTON’S DISEASE TREATMENT MARKET SIZE, BY PSYCHIATRIC SYMPTOM T
Samples
LOADING...
Companies Mentioned
The companies profiled in this Huntington’s Disease Treatment Market report include:- Teva Pharmaceutical Industries Ltd
- H. Lundbeck A/S
- Roche Holding AG
- Ionis Pharmaceuticals, Inc.
- Wave Life Sciences Ltd
- uniQure N.V.
